Key result
Luteolin-4'-O-β-D-glucopyranoside concentration-dependently inhibits platelet aggregation induced by ADP, U46619, and arachidonic acid.
Why the study?
The antiplatelet effects and mechanisms of luteolin-4'-O-β-D-glucopyranoside from Callicarpa nudiflora were not fully elucidated.
Does luteolin-4'-O-β-D-glucopyranoside inhibit platelet aggregation and activation in vitro?
Does luteolin-4'-O-β-D-glucopyranoside inhibit platelet aggregation and activation in vitro?
Effect estimate: IC50 74.9 µM
p-value: p=<0.01
LGP, a natural compound from Callicarpa nudiflora Hook, inhibits platelet aggregation and activation in vitro, likely via dual-receptor inhibition of P2Y12 and TP receptors.
May support antiplatelet development of luteolin glycosides; hypothesis-generating and leaves open clinical translation.
Platelet activation and subsequent accumulation at sites of vascular injury are central to thrombus formation, which is considered to be a trigger of several cardiovascular diseases. Callicarpa nudiflora (C. nudiflora) Hook is a traditional Chinese medicinal herb for promoting blood circulation by removing blood stasis. In our previous study, several compounds extracted from this herb, including luteolin‑4'‑O‑β‑D‑glucopyranoside (LGP), were revealed to exert inhibitory effects on adenosine diphosphate (ADP)‑induced platelet aggregation. The aim of present study was to confirm these antiplatelet effects and elucidate the potential mechanisms. Using a platelet‑aggregation assay, it was revealed that LGP significantly inhibited platelet aggregation induced by ADP, U46619 and arachidonic acid. It was also found that LGP exhibited marked inhibitory effects on the activation of αIIbβ3 integrin, the secretion of serotonin from granules, and the synthesis of thromboxane A2. In addition, the results showed that LGP suppressed Ras homolog family member A and phosphoinositide 3‑kinase/Akt/glycogen synthase kinase 3β signal transduction. Data from a radiolabeled ligand‑binding assay indicated that LGP exhibited apparent competing effects on thromboxane receptor (TP) and P2Y12 receptors. In conclusion, the data presented here demonstrated that LGP, a natural compound from C. nudiflora Hook, inhibited the development of platelet aggregation and amplification of platelet activation. These inhibitory effects may be associated with its dual‑receptor inhibition on P2Y12 and TP receptors.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2018) studied Platelet activation (n=80). Luteolin-4'-O-β-D-glucopyranoside (LGP) vs. Vehicle (DMSO) was evaluated on Platelet aggregation induced by ADP (IC50 74.9 µM, p=<0.01). Luteolin-4'-O-β-D-glucopyranoside significantly inhibited platelet aggregation induced by ADP, U46619, and arachidonic acid in a concentration-dependent manner.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: